Chris Rétif is an Investor at Inven2, whose known portfolio counts 1 company.
Is Chris Rétif a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Stage
- Series A
- Sector
- Healthcare
- Focus
- BiotechDrug DiscoveryHealthcare OperationsTechnology Transfer Office
Contacts
Affiliated funds' portfolios
Investor at Inven2, whose known portfolio counts 1 company
- Tribune Therapeutics
Investor Profile
Chris Rétif is listed against sector Healthcare, and focus areas Biotech, Drug Discovery, Healthcare Operations and Technology Transfer Office in the database.
The stage tag on this profile is Series A.
The firm portfolio and the focus above give founders context on whether Chris Rétif matches their raise.
Frequently asked questions
Who is Chris Rétif?
Chris Rétif is a corporate venture investor based in Oslo, Norway, listed as Investor at Inven2. The known portfolio of that firm is one company. That portfolio belongs to the firm, not to Chris Rétif personally.
What does Chris Rétif invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Drug Discovery, Healthcare Operations and Technology Transfer Office. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Chris Rétif invest at?
Inven2 is listed for Series A rounds in the database, and Chris Rétif is listed there as Investor. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Chris Rétif listed at?
Chris Rétif is listed as Investor at Inven2, whose known portfolio is one company.
How do I contact Chris Rétif?
A LinkedIn page is on file for Chris Rétif. It is readable inside RaiseHunt after you create an account. The database holds no email address and no phone number for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal